USPTO serial 79117132
AMOK
Reviewed by CopyMark Law Group
Reg. 4394377Status 404
- Filing date
- Status date
- Registration date
- Sep 3, 2013
- Examiner
- BIDDULPH, HEATHER ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AMOK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard N. Aronson
Howard N. Aronson Lackenbach Siegel LLPOne Chase RoadScarsdale, NY 10583UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics supporting slimming down and everyday body care, namely, bath oils for cosmetic purposes, skin lotions, nutritional oils for cosmetic purposes, perfumes and perfume preparations, toilet waters, colognes, scented body spray, body deodorants, antiperspirants, essential oils, cosmetic creams, non-medicated ointments for cosmetic purposes, beauty masks, cosmetic milks, cosmetic talcum powder, soaps, fragrance sachets, cosmetics for hair care | SECTION 71 - CANCELLED | — |
| 005 | Drugs for humans, namely, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical preparations, namely, anticoagulants, pharmaceutical preparations, namely, antidepressants, pharmaceutical preparations, namely, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, pharmaceutical preparations, namely, an analgesic for human consumption taken orally, pharmaceutical preparations, namely, injectable contraceptives, pharmaceutical preparation for skin care, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for reducing sexual activity, pharmaceutical preparations for treating dandruff, pharmaceutical products and preparations against dry skin caused by pregnancy, pharmaceutical products and preparations for chloasma, pharmaceutical products and preparations for hydrating the skin during pregnancy, pharmaceutical products and preparations for pregnancy blemishes, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products and preparations to prevent stretch marks, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical products for ophthalmological use, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical products for the treatment of joint disease, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for treating respiratory diseases, pharmaceutical skin lotions, pharmaceutical solutions used in dialysis, pharmaceuticals for the treatment of erectile dysfunction; auxiliary and supporting drugs, namely, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceutical for the treatment of erectile dysfunction, pharmaceutical preparations, namely, anticoagulants, pharmaceutical preparations, namely, antidepressants, pharmaceutical preparations, namely, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, pharmaceutical preparations, namely, an analgesic for human consumption taken orally, pharmaceutical preparations, namely, injectable contraceptives, pharmaceutical preparation for skin care, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for reducing sexual activity, pharmaceutical preparations for treating dandruff, pharmaceutical products and preparations against dry skin caused by pregnancy, pharmaceutical products and preparations for chloasma, pharmaceutical products and preparations for hydrating the skin during pregnancy, pharmaceutical products and preparations for pregnancy blemishes, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products and preparations to prevent stretch marks, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical products for ophthalmological use, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical products for the treatment of joint disease, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for treating respiratory diseases, pharmaceutical skin lotions, pharmaceutical solutions used in dialysis, pharmaceuticals for the treatment of erectile dysfunction; drugs in liquid form, namely, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceutical for the treatment of erectile dysfunction, pharmaceutical preparations, namely, anticoagulants, pharmaceutical preparations, namely, antidepressants, pharmaceutical preparations, namely, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, pharmaceutical preparations, namely, an analgesic for human consumption taken orally, pharmaceutical preparations, namely, injectable contraceptives, pharmaceutical preparation for skin care, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for reducing sexual activity, pharmaceutical preparations for treating dandruff, pharmaceutical products and preparations against dry skin caused by pregnancy, pharmaceutical products and preparations for chloasma, pharmaceutical products and preparations for hydrating the skin during pregnancy, pharmaceutical products and preparations for pregnancy blemishes, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products and preparations to prevent stretch marks, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical products for ophthalmological use, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical products for the treatment of joint disease, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for treating respiratory diseases, pharmaceutical skin lotions, pharmaceutical solutions used in dialysis, pharmaceuticals for the treatment of erectile dysfunction; ointments for pharmaceutical purposes, namely, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical preparations, namely, anticoagulants, pharmaceutical preparations, namely, antidepressants, pharmaceutical preparations, namely, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, pharmaceutical preparations, namely, an analgesic for human consumption taken orally, pharmaceutical preparations, namely, injectable contraceptives, pharmaceutical preparation for skin care, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for reducing sexual activity, pharmaceutical preparations for treating dandruff, pharmaceutical products and preparations against dry skin caused by pregnancy, pharmaceutical products and preparations for chloasma, pharmaceutical products and preparations for hydrating the skin during pregnancy, pharmaceutical products and preparations for pregnancy blemishes, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products and preparations to prevent stretch marks, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical products for ophthalmological use, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical products for the treatment of joint disease, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for treating respiratory diseases, pharmaceutical skin lotions, pharmaceutical solutions used in dialysis, pharmaceuticals for the treatment of erectile dysfunction; drugs for treating constipation, tranquilizing drugs, laxatives, analgesics, hygienic bandages, dressing gauze, gauzes for medical purposes, sponge for wounds, sticking plasters for medical purposes, balsams for medical purposes, therapeutic medicated bath preparations; chemical-pharmaceutical, bacteriological, bacterial and biological preparations for medical purposes, namely, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceutical for the treatment of erectile dysfunction, pharmaceutical preparations, namely, anticoagulants, pharmaceutical preparations, namely, antidepressants, pharmaceutical preparations, namely, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, pharmaceutical preparations, namely, an analgesic for human consumption taken orally, pharmaceutical preparations, namely, injectable contraceptives, pharmaceutical preparation for skin care, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for reducing sexual activity, pharmaceutical preparations for treating dandruff, pharmaceutical products and preparations against dry skin caused by pregnancy, pharmaceutical products and preparations for chloasma, pharmaceutical products and preparations for hydrating the skin during pregnancy, pharmaceutical products and preparations for pregnancy blemishes, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products and preparations to prevent stretch marks, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical products for ophthalmological use, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical products for the treatment of joint disease, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for treating respiratory diseases, pharmaceutical skin lotions, pharmaceutical solutions used in dialysis, pharmaceuticals for the treatment of erectile dysfunction; enzymes for pharmaceutical and medical purposes, dietetic substances for therapeutic purposes, namely, dietetic sugar substitute for medical use, food articles for infants; disinfecting agents, namely, all-purpose disinfectant; sanitary preparations for therapeutic purposes; protein-rich nutritional supplement concentrates and supplements enriched with vitamins, mineral salts and amino acids; carbohydrate nutritional supplement concentrates and supplements | SECTION 71 - CANCELLED | — |
| 016 | Newspapers; catalogues and books in the field of nutrition, exercise, sport, hygiene, pharmacy | SECTION 71 - CANCELLED | — |
| 029 | Dairy products excluding ice cream, ice milk and frozen yogurt; milk, yoghurts, kefirs, cheeses, protein milk, wheys, milk drinks or drinks with predominance of milk, egg whites, meat extracts, preserved, dried and cooked fruits and vegetables, edible oils and fats | SECTION 71 - CANCELLED | — |
| 030 | Energy-rich bakery products containing vitamins and mineral salts; special bakery products, namely, cereal based energy bars, chocolate-based meal replacement bars; breakfast cereals, including muesli, corn flakes, porridge oats and bran, farinaceous foods namely bread; cereal preparations, namely, cereal-based snack foods, biscuits, tarts, cakes made with cereals; soy flour; coffee and chocolate based drinks | SECTION 71 - CANCELLED | — |
| 032 | Non-alcoholic aromatized beverages based on fruit, protein, cordial, sugar and other fluid nutrients, namely, carbohydrate drinks for use as a food fillers enriched with vitamins and minerals and protein drinks for use as a food fillers enriched with vitamins and minerals; whey drinks, isotonic drinks, fruit juice drinks, fruit nectars; non-alcoholic aromatized beverages based on fruit, protein, cordial, sugar and other fluid nutrients, namely, guarana drinks, isotonic drinks; energy drinks; extracts from fruits, namely, non-alcoholic fruit extracts used in the preparation of beverages; alcohol-free fruit extracts, namely, non-alcoholic fruit extracts used in the preparation of beverages; carbonated and mineral water; juices, namely, apple juice, orange juice; syrups used in the preparation of sport and energy drinks; fruit and vegetable juices | SECTION 71 - CANCELLED | — |
| 035 | The bringing together, for third parties, of various goods, enabling customers to conveniently view and purchase those goods and enabling customers to conveniently view and purchase those goods in shops, wholesale outlets and on websites in particular of cosmetics for athletes, cosmetics supporting slimming down and everyday body care, perfumes and perfume preparations, toilet waters, colognes, fragrant waters, deodorants, antiperspirants, essential oils, creams, ointments, face masks, cosmetic milks, cosmetic talcum powder, soaps, fragrance mixes, preparations for shaving and depilation, cosmetics for tanning, shampoos, bath salts, cosmetics for hair care, tooth cleaning preparations, drugs for humans, auxiliary and supporting drugs, drugs in liquid form, ointments for pharmaceutical purposes, drugs for constipation, tranquilizing drugs, laxatives, analgesic drugs, medical preparations for hair restoring, medicinal herbs, hormones for medical purposes, dressing materials, hygienic bandages, dressing bandages, dressing gauze, gauzes for medical purposes, sponge for wounds, sticking plaster for medical purposes, balsams for therapeutic purposes, therapeutic preparations for bath, chemical-pharmaceutical, bacteriological, bacterial and biological preparations for medical purposes, enzymes for pharmaceutical and medical purposes, salts for mineral baths, dietetic substances for therapeutic purposes, food products for infants, disinfecting agents, sanitary preparations for therapeutic purposes, energizing food supplements containing pharmaceutical preparations used prophylactically and for convalescents, newspapers, catalogues, books, dairy products, milk, yoghurts, kefirs, milk proteins, wheys, milk drinks or drinks with predominance of milk, egg whites, food proteins, meat extracts, preserved, dried and cooked fruits and vegetables, edible oils and fats, protein-rich concentrates and supplements enriched with vitamins, mineral salts and amino acids, bakery products, special bakery products, dietetic bakery products, breakfast mixes including muesli, corn flakes, porridge oats, bran, farinaceous products, cereal products, coffee and chocolate drinks. soy, hydrocarbon concentrates and supplements as well as energy-rich bakery products supplemented with vitamins and mineral salts, alcohol-free beverages, alcohol-free aperitifs, extracts from fruits, alcohol-free fruit extracts, carbonated and mineral water, juices, syrups for drinks, whey drinks, fruit juice drinks, fruit nectars, hydrocarbon and energy drinks, non-alcoholic beverages enriched with vitamins and minerals and fruit and vegetable juices; internet retail store services featuring the all of aforementioned goods; advertising and marketing services | SECTION 71 - CANCELLED | — |
| 044 | Information and advisory concerning health care; dietetic consultancy services; health and beauty care information and advisory concerning use of products designed for health and beauty care | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OLIMP LABORATORIES Sp. z o.o.
- Other trademarks owned by OLIMP LABORATORIES Sp. z o.o.
- Other trademarks owned by OLIMP LABORATORIES Sp. z o.o.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 032
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named AMOK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Oct 24, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 29, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 29, 2021 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 29, 2021 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Apr 25, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 3, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 30, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 5, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 3, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 3, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 18, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 14, 2013 | ALIE | ASSIGNED TO LIE | — |
| May 6, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 8, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2013 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 8, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 8, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 8, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 2, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 17, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 25, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 25, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 23, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 22, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 20, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |